NasdaqGM:LGNDPharmaceuticals
Is Ligand Pharmaceuticals (LGND) Still Attractive After Its 165.7% Three Year Share Price Surge
If you are wondering whether Ligand Pharmaceuticals at around US$195 a share still offers value, the next sections will walk through what the current price might be implying about the business.
The stock has delivered an 81.6% return over 1 year and 165.7% over 3 years, while the shorter term picture shows a 4.6% decline over 7 days alongside modest gains of 2.1% over 30 days and 2.8% year to date.
Recent coverage of Ligand Pharmaceuticals has focused on its role in the wider pharmaceuticals...